Cancer therapy finds a solid target
Copyright policy )Cancer therapy finds a solid target
Most molecular targets for treating cancer prove to be busts. Broadly applicable anticancer therapies have been particularly difficult to develop because of the multiplicity of genetic mutations in a cancer cell: target one mutation and another will slip by, potentially causing the therapy to be
STAT3 Transcription Factor, Lymphoma, Non-Hodgkin, Antineoplastic Agents, Apoptosis, Breast Neoplasms, Oligonucleotides, Antisense, DNA-Binding Proteins, Mice, Neoplasms, Trans-Activators, Tumor Cells, Cultured, Animals, Humans
STAT3 Transcription Factor, Lymphoma, Non-Hodgkin, Antineoplastic Agents, Apoptosis, Breast Neoplasms, Oligonucleotides, Antisense, DNA-Binding Proteins, Mice, Neoplasms, Trans-Activators, Tumor Cells, Cultured, Animals, Humans
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).2 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!